Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to $495000.0.

  • Altimmune's Interest Expenses rose 815000.0% to $495000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $761000.0, marking a year-over-year increase of 751000.0%. This contributed to the annual value of $9000.0 for FY2024, which is 7428.57% down from last year.
  • As of Q3 2025, Altimmune's Interest Expenses stood at $495000.0, which was up 815000.0% from $264000.0 recorded in Q2 2025.
  • Over the past 5 years, Altimmune's Interest Expenses peaked at $495000.0 during Q3 2025, and registered a low of -$183000.0 during Q4 2022.
  • Moreover, its 5-year median value for Interest Expenses was $6000.0 (2024), whereas its average is $43000.0.
  • As far as peak fluctuations go, Altimmune's Interest Expenses crashed by 327460.32% in 2021, and later surged by 2630000.0% in 2025.
  • Over the past 5 years, Altimmune's Interest Expenses (Quarter) stood at -$62000.0 in 2021, then plummeted by 195.16% to -$183000.0 in 2022, then skyrocketed by 101.09% to $2000.0 in 2023, then tumbled by 50.0% to $1000.0 in 2024, then soared by 49400.0% to $495000.0 in 2025.
  • Its Interest Expenses was $495000.0 in Q3 2025, compared to $264000.0 in Q2 2025 and $1000.0 in Q1 2025.